Cresilon Partners with McCarthy Vet to Distribute VETIGEL
Cresilon Inc., an innovative biotechnology firm known for its advanced hemostatic products, has announced a transformative agreement with McCarthy Vet. This collaboration marks a significant step forward as it allows for the distribution of VETIGEL, a groundbreaking hemostatic gel, directly to veterinary surgeons. This product will enhance surgical care for animals in Canada, allowing for more effective treatment options.
VETIGEL: A Revolutionary Solution
VETIGEL stands out as a plant-based hemostatic gel designed to instantly stop bleeding during various surgical procedures. It is now available to veterinary professionals across Canada, thanks to the refined partnership with McCarthy Vet, a trusted name in veterinary supplies with over 60 years of experience.
Why VETIGEL is Important for Veterinary Practices
The unique formulation of VETIGEL is designed to simplify the surgical process. It acts as a mechanical barrier that stops bleeding on contact and can be easily removed or left in place to resorb naturally. This not only enhances efficiency during operations but also improves overall patient outcomes by minimizing the time an animal spends under anesthesia.
Veterinary surgeons are increasingly recognizing VETIGEL as an essential tool in their practice. Since its launch, it has been utilized in thousands of procedures across North America, Europe, and Asia, gaining traction as a go-to solution for managing bleeding in critical surgical scenarios such as dental extractions, tumor removals, and more complex surgeries.
Impact of the Partnership
With this new agreement, McCarthy Vet will introduce VETIGEL to veterinary professionals, thus fulfilling their commitment to delivering the most cutting-edge solutions in animal healthcare. The partnership underscores both entities' dedication to improving the veterinary field through innovative and effective products.
Quality Assurance and Efficacy
What sets VETIGEL apart is its biocompatibility and the fact that it is non-animal derived. This allows for a wider scope of comfort among veterinarians when using it on their animal patients. The ease of application without any need for additional preparation further enhances its appeal among veterinary staff, saving time while ensuring high-quality care.
As the veterinary landscape evolves, Cresilon’s mission remains steadfast: to innovate and enhance the medical response for animals in need. The introduction of VETIGEL into Canadian practices is a testament to this commitment.
Learn More About Cresilon and McCarthy Vet
Cresilon's background is rooted in biotechnological advancements, particularly in the realm of hemostatic devices. Their flagship product, VETIGEL, harnesses proprietary hydrogel technology, leading the way for future developments in trauma care and animal health sectors. This innovative approach not only meets but exceeds the current standards in veterinary medicine.
Meanwhile, McCarthy Vet has built a reputation over six decades as a reliable supplier to veterinarians. Their commitment to providing high-quality, innovative solutions plays a crucial role in supporting animal health across Canada.
Frequently Asked Questions
What is VETIGEL?
VETIGEL is a plant-based hemostatic gel designed to control bleeding during veterinary surgical procedures.
How does VETIGEL improve veterinary care?
It provides a fast and effective solution to stop bleeding, improving patient outcomes and reducing surgical time.
Who is McCarthy Vet?
McCarthy Vet is a leading full-service veterinary marketing and supply company serving veterinarians in Canada for over 60 years.
What surgical procedures can benefit from VETIGEL?
Any surgical procedure involving potential blood loss, including dental work, tumor removals, and more complex surgeries, can benefit from its application.
Where can I find more information about Cresilon?
For further details about Cresilon and their innovative products, visit their official website.
